Directors: Prof Patrick YUNG and Prof Woody CHAN

Company

CNRM combines the talents and expertise in stem cells, biomaterials, 3D bioprinting, tissue engineering, and personalized and translational medicine from CUHK and the Karolinska Institutet (KI). The CNRM will build on the infrastructural research capabilities and facilities of CUHK and the research set-up of the KI Hong Kong Ming Wai Lau Centre for Reparative Medicine located at the HKSTP. A rigorous and progressive transition and commercialization as well as industrial partnerships and patient advocacy will be pursued for efficient and effective evaluation and translation of the therapeutic agents, procedures, and technologies derived from CNRM research activities.